Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
M. Greaves.
Antiphospholipid antibodies and trhrombosis.
Lancet, 353 (1999), pp. 1.348-1.353
[2.]
R.T. Canoso, L.I. Zon, J.E. Groopman.
Anticardiolipin antibodies associated with HTLV-III infection.
Br J Haematol, 65 (1987), pp. 495-498
[3.]
M.M. Stimmler, F.P. Jr Quismorio, W.G. McGehee, T. Boylen, O.P. Sharma.
Anticaridolipin antibodies in acquired immunodeficiency syndrome.
Arch Intern Med, 149 (1989), pp. 1.833-1.835
[4.]
W.B. Van Leeuwen, M.T. Jaroch, T.A. Broughan, R.E. Hermann.
The natural history of splenic infarction.
Surgery, 100 (1986), pp. 743-750
[5.]
J.H. Jr. O’Keefe, D.R. Jr Holmes, H.V. Schaff, P.F. II Sheedy, W.D. Edwards.
Thromboembolic splenic infarction.
Mayo Clin Proc, 61 (1986), pp. 967-972
[6.]
S. Mitchell, M.D. Cappel, D.O. Todd Simón, M.D. Moti Tiku.
Splenic infarction associated with anticardiolipin antibodies in a patient with acquired immunodeficiency syndrome.
Digestive Diseases and Sciences, 37 (1993), pp. 1.152-1.155
[7.]
T.P. Obarski, J.K. Stoller, C. Winstein, S. Hayden.
Splenic infaction: A new thrombotic manifestation of the circulating lupus anticoagulant.
Cleveland Clin J Med, 56 (1989), pp. 174-176
[8.]
J. Eldrup-Jorgensen, L. Brace, P. Flanigan, T.H. Schwarez, G. Fritsma, J.P. Meyer, et al.
Lupus-like anticoagulants and lower extremity arterial occlusive disease.
Circulation, 80 (1989), pp. 54-58
[9.]
S.R. Leviene, M.J. Deegan, N. Futrell, K.M.A. Welch.
Cerebrovasculr and neurologic disease associated with antiphospholipid antibodies: 48 cases.
Neurology, 40 (1990), pp. 1.181-1.189
[10.]
A.J. Cohen, T.M. Philips, C.M. Kessler.
Circulating coagulation inhibitors in the acquired immunodeficiency syndrome.
Ann Intern Med, 104 (1986), pp. 175-180
[11.]
M. Galli, P. Comfurius, C. Massen, H.C. Hemker, M.H. de Baets, P.J. van Bread-Vriesman, et al.
Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein factor.
Lancet, 355 (1990), pp. 1.544-1.547
[12.]
H.P. Mc Neil, J. Simpson, C.N. Chesterman, S.A. Krilis.
Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta-2-glycoprotein (apolipoprotein H).
Proc Nat Acad Sci USA, 87 (1990), pp. 4.120-4.124
[13.]
J. Coll, H. Yazbeck, J.M. Garces, A. Berges, F. Prats, J. Rubies-Prat.
Anticardiolipin antibodies and Pneumocystis carinii in patients with AIDS.
J Infect, 21 (1990), pp. 120
[14.]
S. Panzer, C. Stain, H. Hartl, R. Dudczak, K. Lechner.
Anticardiolipin antibodies are elevated in HIV-1 infected haemophilics but not predict for disease progression.
Thromb Hemost, 61 (1989), pp. 81-85
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
